CGP 3466B maleate (Omigapil maleate) is an orally bioavailable GAPDH nitrosylation inhibitor. Omigapil maleate abrogates Abeta1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice. Omigapil maleate has the potential for the research of Alzheimers disease. Omigapil maleate (CGP3446B maleate) is a apoptosis inhibitor. Omigapil maleate can be used for the research of congenital muscular dystrophy (CMD).
Molecular Weight:
391.42
Purity:
98.96%
CAS Number:
[200189-97-5]
Formula:
C23H21NO5
Target:
Apoptosis
T21792
* VAT and and shipping costs not included. Errors and price changes excepted
